Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Gibson

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Nature Medicine|October 19, 2021
Distinction of lymphoid and myeloid clonal hematopoiesisAbhishek Niroula, Aswin Sekar, Mark A Murakami, et al.
The Journal of Molecular Diagnostics : JMD|July 1, 2020
Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing PlatformsHarrison K Tsai, Diane G Brackett, David Szeto, et al.
Blood|June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantationPhilippe Armand, Christopher J Gibson, Corey Cutler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2024
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin LymphomaChengcheng Yan, Melissa A Richard, Christopher J Gibson, et al.
Leukemia & Lymphoma|June 1, 2016
Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variantEmily F Mason, Ronald D Brown, David P Szeto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 StudyJurjen Versluis, Wael Saber, Harrison K Tsai, et al.
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Sex-Based Differences in Risk of Therapy-Related Myeloid NeoplasmsMelissa A Richard, Chengcheng Yan, Yanjun Chen, et al.
Blood Advances|September 25, 2024
Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemiaAbi Vijenthira, Virginia O Volpe, Aswin Sekar, et al.
NEJM Evidence|July 24, 2023
Prediction of risk for myeloid malignancy in clonal hematopoiesisLachelle D Weeks, Abhishek Niroula, Donna Neuberg, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Nature Medicine|October 19, 2021
Distinction of lymphoid and myeloid clonal hematopoiesisAbhishek Niroula, Aswin Sekar, Mark A Murakami, et al.
The Journal of Molecular Diagnostics : JMD|July 1, 2020
Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing PlatformsHarrison K Tsai, Diane G Brackett, David Szeto, et al.
Blood|June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantationPhilippe Armand, Christopher J Gibson, Corey Cutler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2024
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin LymphomaChengcheng Yan, Melissa A Richard, Christopher J Gibson, et al.
Leukemia & Lymphoma|June 1, 2016
Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variantEmily F Mason, Ronald D Brown, David P Szeto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 StudyJurjen Versluis, Wael Saber, Harrison K Tsai, et al.
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Sex-Based Differences in Risk of Therapy-Related Myeloid NeoplasmsMelissa A Richard, Chengcheng Yan, Yanjun Chen, et al.
Blood Advances|September 25, 2024
Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemiaAbi Vijenthira, Virginia O Volpe, Aswin Sekar, et al.
NEJM Evidence|July 24, 2023
Prediction of risk for myeloid malignancy in clonal hematopoiesisLachelle D Weeks, Abhishek Niroula, Donna Neuberg, et al.
Pageof 9